Stock screenerAll disclosures →
EDGAR →
BTAI
Conviction 0HealthcareScan · Mon, Aug 10, 2026BTAI$0.9215+2.20%
ResistanceSupportVol 14Insider sell4
Vol MA14 415.37K
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +100.00%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.9215
Change+2.20%
Gap-0.19%
Rel volume0.43×
Avg volume717.43K
Avg $ vol661.16K
SMA 200.8702
SMA 501.04
SMA 2001.46
Price vs 50-11.71%
Price vs 200-37.05%
MA stackbearish
50/200 cross—
Supertrenddown · 1.03
RSI (14)50
MACD hist0.02
MACD crossbull · 5d
Stoch %K / %D86 / 74
ADX (14)14
+DI / −DI27 / 25
RSI divergence—
MACD divergenceBullish
ATR %+8.32%
ADR %8.50%
52w high6.80
52w low0.7928
From 52w high-86.45%
Above 52w low+16.23%
New 52w highNo
SqueezeFired
Bollinger width23.39%
%B0.75
Donchian pos41.36%
Donchian high1.17
Donchian low0.7462
AVWAP (52w high)3.34
vs AVWAP high-72.44%
AVWAP (52w low)0.9033
vs AVWAP low+2.01%
OBV trendUp
Chaikin MF (20)-0.07
Today vs 20d0.43×
Avg vol (14d)415.37K
Avg vol (20d)717.43K
Avg $ vol (20d)661.16K
Market cap—
RS 3m (vs SPY)-32.98%
RS 6m (vs SPY)-48.30%
RS line new highNo
Trend template0/8
Technical rank23.3
1 week+8.72%
1 month+12.72%
3 months-24.47%
6 months-38.57%
1 year-72.98%
YTD-45.79%
P/E-0.40
P/B-0.27
P/S43.94
P/FCF-0.49
EPS-5.73
Div yield—
ROE66.23%
ROA-205.43%
Debt/Eq-0.95
Current0.62
EV/EBITDA-2.22
Gross margin—
Net margin—
Rev growth-71.67%
EPS growth-17.28%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value111.32M
Revenue206K
Net income-12.69M
Gross profit—
Free cash flow-57.62M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out30.88M
Employees29
ListedThu, Mar 8, 2018
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank23.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.41
Support0.7413
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BTAI
No recent disclosed trades by Congress in BTAI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BTAI · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Yocca Frank Chief Scientific Officer · Restricted Stock Units · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Rodriguez Javier See Remarks · Common Stock · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Mehta Vimal CEO and President · Common Stock · 2026-06-15 | Exercise | 219 | — | 2026-06-15 | 2026-06-17 |
Yocca Frank Chief Scientific Officer · Common Stock · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Steinhart Richard I Chief Financial Officer · Common Stock · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Steinhart Richard I Chief Financial Officer · Restricted Stock Units · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Mehta Vimal CEO and President · Restricted Stock Units · 2026-06-15 | Exercise | 219 | — | 2026-06-15 | 2026-06-17 |
Rodriguez Javier See Remarks · Restricted Stock Units · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Yocca Frank Chief Scientific Officer · Common Stock · 2026-05-20 | Sell | 6.84K | $7K | 2026-05-20 | 2026-05-22 |
Mehta Vimal CEO and President · Common Stock · 2026-05-20 | Sell | 19.42K | $21K | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in BTAI · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.